New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
Surviving a silent threat: A young mother's journey with pulmonary embolism [CBS News]
Penumbra (PEN) had its "neutral" rating reaffirmed by UBS Group AG.
Penumbra (PEN) had its "outperform" rating reaffirmed by Evercore Inc.